ACHV
ACHV
NASDAQ · Biotechnology

Achieve Life Sciences Inc

$4.25
+0.30 (+7.59%)
As of Feb 8, 2:04 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 635.25M 656.40M 699.53M
Net Income 12.40M 10.36M 12.63M
EPS
Profit Margin 2.0% 1.6% 1.8%
Rev Growth +11.6% +1.9% +12.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 16.85M 15.37M 15.24M
Total Equity 124.95M 127.45M 128.08M
D/E Ratio 0.13 0.12 0.12
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 19.03M 18.53M 18.96M
Free Cash Flow 7.11M 6.70M 12.14M